Trevi Therapeutics Stock Price on November 14, 2024
| TRVI Stock | USD 2.91 0.18 6.59% |
Below is the normalized historical share price chart for Trevi Therapeutics extending back to May 07, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Trevi Therapeutics stands at 2.91, as last reported on the 23rd of November, with the highest price reaching 2.93 and the lowest price hitting 2.66 during the day.
If you're considering investing in Trevi Stock, it is important to understand the factors that can impact its price. Trevi Therapeutics is unstable at the moment. Trevi Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.01, which indicates the firm had a 0.01% return per unit of risk over the last 3 months. We have found thirty technical indicators for Trevi Therapeutics, which you can use to evaluate the volatility of the company. Please validate Trevi Therapeutics' Semi Deviation of 3.64, coefficient of variation of 2524.62, and Risk Adjusted Performance of 0.0385 to confirm if the risk estimate we provide is consistent with the expected return of 0.0395%.
As of now, Trevi Therapeutics' Common Stock Shares Outstanding is increasing as compared to previous years. The Trevi Therapeutics' current Sale Purchase Of Stock is estimated to increase to about 141.5 M, while Total Stockholder Equity is projected to decrease to under 41.7 M. . As of now, Trevi Therapeutics' Price Book Value Ratio is increasing as compared to previous years. The Trevi Therapeutics' current Price To Book Ratio is estimated to increase to 1.69, while Price Earnings Ratio is projected to decrease to (4.79). Trevi Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of May 2019 | 200 Day MA 2.9029 | 50 Day MA 3.1067 | Beta 1.014 |
Trevi |
Sharpe Ratio = 0.01
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TRVI |
Estimated Market Risk
| 3.94 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Trevi Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Trevi Therapeutics by adding Trevi Therapeutics to a well-diversified portfolio.
Price Book 3.5585 | Book Value 0.782 | Enterprise Value 145.5 M | Enterprise Value Ebitda (4.92) | Shares Float 47.8 M |
Related Headline
Cue Biopharma Headline on 14th of November 2024
Cue BiopharmaReports Third Quarter 2024 Financial Results an... by globenewswire.com
BOSTON, Nov. 14, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of...
Trevi Therapeutics Valuation on November 14, 2024
It is possible to determine the worth of Trevi Therapeutics on a given historical date. On November 14, 2024 Trevi was worth 2.87 at the beginning of the trading date compared to the closed value of 2.86. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Trevi Therapeutics stock. Still, in general, we apply an absolute valuation method to find Trevi Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Trevi Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Trevi Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.04 | 3.10 | 2.83 | 2.86 | 288,531 | |
11/14/2024 | 2.87 | 3.01 | 2.81 | 2.86 | 1,098,991 |
| 2.90 | 2.92 | 2.67 | 2.75 | 500,277 |
| Backtest Trevi Therapeutics | | | Trevi Therapeutics History | | | Trevi Therapeutics Valuation | Previous | Next |
Trevi Therapeutics Trading Date Momentum on November 14, 2024
| On November 15 2024 Trevi Therapeutics was traded for 2.75 at the closing time. The top price for the day was 2.92 and the lowest listed price was 2.67 . The trading volume for the day was 500.3 K. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 3.85% . The trading price change against the current closing price is 4.55% . |
Trevi Therapeutics Fundamentals Correlations and Trends
By evaluating Trevi Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Trevi Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Trevi financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Trevi Therapeutics Stock history
Trevi Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Trevi is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Trevi Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Trevi Therapeutics stock prices may prove useful in developing a viable investing in Trevi Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 99 M | 104 M | |
| Net Loss | -26.2 M | -27.5 M |
Trevi Therapeutics Quarterly Net Working Capital |
|
Trevi Therapeutics Stock Technical Analysis
Trevi Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Trevi Therapeutics Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Trevi Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Trevi Therapeutics November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Trevi Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Trevi Therapeutics shares will generate the highest return on investment. By undertsting and applying Trevi Therapeutics stock market strength indicators, traders can identify Trevi Therapeutics entry and exit signals to maximize returns
Trevi Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Trevi Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Trevi Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Trevi to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0385 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.49) | |||
| Sortino Ratio | 0.0073 | |||
| Treynor Ratio | 0.0794 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Trevi Stock analysis
When running Trevi Therapeutics' price analysis, check to measure Trevi Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trevi Therapeutics is operating at the current time. Most of Trevi Therapeutics' value examination focuses on studying past and present price action to predict the probability of Trevi Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trevi Therapeutics' price. Additionally, you may evaluate how the addition of Trevi Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |